DUCA, LORENA
DUCA, LORENA
DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study
2022 D. Maira, L. Duca, F. Busti, D. Consonni, M. Salvatici, A. Vianello, A. Milani, A. Guzzardella, E. Di Pierro, S. Aliberti, I.M. Baldini, A. Bandera, F. Blasi, E. Cassinerio, M. Cesari, A.L. Fracanzani, G. Grasselli, G. Graziadei, R. Lombardi, G. Marchi, N. Montano, V. Monzani, F. Peyvandi, M. Proietti, M. Sandri, L. Valenti, M.D. Cappellini, D. Girelli, A. Protti, I. Motta
Epidemiological shift of glucose-6-phosphate dehydrogenase mutations in Northern Italy in the last 15 years
2021 L. Duca, I. Nava, D. Tavazzi, A. Marcon, I. Motta, G. Graziadei
Alternative Pathway Involvement in Protoporphyria Patients Related to Sun Exposure
2021 F. Granata, L. Duca, V. Brancaleoni, S. Fustinoni, G. De Luca, I. Motta, G. Graziadei, E. Di Pierro
Differential redox state and iron regulation in chronic obstructive pulmonary disease, acute respiratory distress syndrome and coronavirus disease 2019
2021 L. Duca, S. Ottolenghi, S. Coppola, R. Rinaldo, M. Dei Cas, F.M. Rubino, R. Paroni, M. Samaja, D.A. Chiumello, I. Motta
The α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study
2021 M. Longo, E. Paolini, M. Meroni, L. Duca, I. Motta, A.L. Fracanzani, E. DI PIERRO, P. Dongiovanni
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study]
2021 M. Longo, E. Paolini, M. Meroni, L. Duca, I. Motta, A.L. Fracanzani, E. Di Pierro, P. Dongiovanni
Activin receptor-ligand trap for the treatment of β-thalassemia : a serendipitous discovery
2020 V. Brancaleoni, I. Nava, P. Delbini, L. Duca, I. Motta
Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation
2019 W. Barcellini, A. Zaninoni, A.I. Gregorini, G. Soverini, L. Duca, B. Fattizzo, J.A. Giannotta, P. Pedrotti, C. Vercellati, A.P. Marcello, E. Fermo, P. Bianchi, M.D. Cappellini
Inflammatory involvement into phototoxic reaction in erythropoietic protoporphyria (EPP) patients
2019 F. Granata, L. Duca, G. Graziadei, V. Brancaleoni, P. Missineo, G. De Luca, S. Fustinoni, E. Di Pierro
Circulating cell-free DNA and ineffective erythropoiesis in nontransfusion-dependent β-thalassemia
2018 D. Tavazzi, I. Motta, G. Graziadei, M. Sampietro, L. Duca, M.D. Cappellini
Non-transferrin-bound iron and oxidative stress during allogeneic hemopoietic stem cell transplantation in patients with or without iron overload
2018 L. Duca, M.D. Cappellini, D. Baronciani, F. Pilo, C. Targhetta, G. Visani, I. Nava, E. Angelucci
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion
2017 F. Cavallaro, L. Duca, L.F. Pisani, R. Rigolini, L. Spina, G.E. Tontini, N. Munizio, E. Costa, M.D. Cappellini, M. Vecchi, L. Pastorelli
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy : kinetics of its appearance and potential predictive role in infectious complications
2015 A. Belotti, L. Duca, L. Borin, S. Realini, R. Renso, M. Parma, P. Pioltelli, E. Pogliani, M.D. Cappellini
Role of Non-Transferrin-Bound Iron in the pathogenesis of cardiotoxicity in patients with ST-elevation myocardial infarction assessed by Cardiac Magnetic Resonance Imaging
2015 A. Roghi, E. Poggiali, L. Duca, A. Mafrici, P. Pedrotti, S. Paccagnini, S. Brenna, A. Galli, D. Consonni, M. Cappellini
Growth differentiation factor 15 expression and regulation during erythroid differentiation in non-transfusion dependent thalassemia
2015 L. Ronzoni, L. Sonzogni, L. Duca, G. Graziadei, M.D. Cappellini, E. Ferru
An intriguing case of anaemia and splenomegaly
2014 E. Poggiali, I. Nava, M. Giuditta, L. Duca, E. Cassinerio
Combination of deferasirox and deferoxamine in clinical practice: An alternative scheme of chelation in thalassemia major patients.
2014 E. Cassinerio, N. Orofino, A. Roghi, L. Duca, E. Poggiali, M. Fraquelli, M.D. Cappellini, L. Zanaboni
Combination of deferasirox and deferoxamine in clinical practice : alternative schemes of chelation in Thalassemia major (TM) patients
2013 E. Cassinerio, L. Zanaboni, A. Roghi, E. Poggiali, I. Gandolfi, M. Mazzoleni, L. Duca, N. Orofino, M. Cappellini
Hepcidin is a pivotal mediator of infliximab-induced improvement of iron metabolism in inflammatory bowel diseases
2012 F. Cavallaro, L. Pastorelli, L. Duca, R. Rigolini, N. Munizio, L. Spina, G.E. Tontini, E. Costa, M.D. Cappellini, M. Vecchi
Erythropoietin in Friedreich ataxia : no effect on frataxin in a randomized controlled trial
2012 C. Mariotti, R. Fancellu, S. Caldarazzo, L. Nanetti, D. Di Bella, M. Plumari, G. Lauria, M..D. Cappellini, L. Duca, A. Solari, F. Taroni